“…The catechol-o-methyltransferase ( COMT ) genotype influences brain functional (including auditory processing, which is highly related to AVHs) and dopaminergic alterations both in healthy people and in patients with schizophrenia ( Lu et al., 2007 ; Kang et al., 2010 ; Gothelf et al., 2011 ; Edgar et al., 2012 ; Tian et al., 2013a , b ; Li et al., 2015 ; Steiner et al., 2018 ) and the efficacy of dopamine antagonists in patients with schizophrenia ( Olgiati et al., 2009 ; Sagud et al., 2010 ; Huang et al., 2016 ). These previous findings converge to indicate that the reciprocal interactions between COMT genotype, dopamine levels, and structural and/or functional alterations in the human brain are related to mental disorder symptoms, such as AVHs ( Lu et al., 2007 ; Kang et al., 2010 ; Sagud et al., 2010 ; Gothelf et al., 2011 ; Edgar et al., 2012 ; Tian et al., 2013a , b ; Li et al., 2015 ; Huang et al., 2016 ; Steiner et al., 2018 ).…”